1-4 of 4
James Rubenstein, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Low-Dose Lenalidomide Maintenance after Induction Therapy in Older Patients with Primary CNS Lymphoma

Khoan Vu, MD, James Rubenstein, MD PhD, Gabriel N. Mannis, MD, Jimmy Hwang, PhD, Huimin Geng, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4230.
https://doi.org/10.1182/blood-2018-99-112767
Published: 2018
Journal Articles

Application of Hyperpolarized 13C Magnetic Resonance Imaging to Detect Target Inhibition of NFkB Activation in Preclinical Patient-Derived Models of CNS Lymphoma

Huimin Geng, PhD, Brice Tiret, PhD, Hua-Xin Gao, PhD, Cigall Kadoch, PhD, Ming Lu, PhD, Lingjing Chen, PhD, Ilwoo Park, PhD, Gerd Melkus, PhD, Adam Elkhaled, PhD, John Kurhanewicz, PhD, Lisa Drew, PhD, Sebastien Degorce, PhD, Michele Mayo, PhD, Keith Dillman, PhD, Rana Anjum, PhD, Andrew Bloecher, PhD, Myriam Chaumeil, PhD, James Rubenstein, MD, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2840.
https://doi.org/10.1182/blood-2018-99-117625
Published: 2018
Journal Articles

Macrophage Polarization and Acquired Resistance to Rituximab in CNS Lymphoma.

Cigall Kadoch, B.S., Valerie D. Wong, Sc.B., Tara Rambaldo, B.S., William Hyun, B.S., Clifford Lowell, MD, PhD, James Rubenstein, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 3749.
https://doi.org/10.1182/blood.V114.22.3749.3749
Published: 2009
Journal Articles

Treatment of Primary CNS Lymphoma with Induction High-Dose Methotrexate, Temozolomide, Rituximab Followed by Consolidation Cytarabine/Etoposide: A Pilot Study with Biomarker Analysis.

Samar Issa, MD, Arthur Shen, B.S., Jon Karch, B.S., Cigall Kadoch, B.S., Marc Shuman, M.D., Lloyd Damon, M.D., James Rubenstein, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 1364.
https://doi.org/10.1182/blood.V110.11.1364.1364
Published: 2007